SEC Form 4 · accession 0000882104-18-000068
PDL BIOPHARMA, INC. · PDLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jody S Lindell
Director
Period of report
Jun 8, 2018
Accepted (ET)
Jun 12, 2018 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882104
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Jun 8, 2018 | A | 54,348 | $2.76 | A | 256,174 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The grant will cliff-vest on the first anniversary of the date of grant so long as the grant recipient continues to serve on the Board of Directors of PDL BioPharma, Inc.